Literature DB >> 12540567

Protection of chickens against Escherichia coli infections by DNA containing CpG motifs.

Susantha Gomis1, Lorne Babiuk, Dale L Godson, Brenda Allan, Tannis Thrush, Hugh Townsend, Philip Willson, Edwin Waters, Rolf Hecker, Andrew Potter.   

Abstract

Synthetic oligodeoxynucleotides (ODN) containing CpG motifs (CpG-ODN) have been shown to be effective immunoprotective agents in murine models for a variety of viral, intracellular bacterial, and protozoan infections. Until now, the use of CpG-ODN to protect against extracellular bacterial infections has not been reported. The objective of this study was to investigate the effect of CpG-ODN against cellulitis and colibacillosis in broiler chickens, using a well-established model. At 22 days of age, birds received CpG-ODN by either the subcutaneous or intramuscular route. Three days later, a virulent isolate of Escherichia coli was applied to a scratch site on the caudal abdominal skin. Birds were examined for 10 days after the E. coli challenge, and pathological and bacteriological assessments were conducted on all birds. The control group of birds receiving no CpG-ODN((2007)) had a survival rate of 15%. In contrast, groups that received CpG-ODN((2007)), by either subcutaneous or intramuscular injection, had significantly higher survival rates (P < 0.0001). Furthermore, the size of the cellulitis lesion was significantly smaller in groups that received CpG-ODN((2007)) by the subcutaneous route (P < 0.01). A dose of as little as 3.16 micro g of CpG-ODN((2007)), delivered 3 days prior to challenge by either the subcutaneous or intramuscular route, significantly protected birds against E. coli infection (P < 0.01). This study demonstrates that CpG-ODN((2007)) has both local and systemic protective effects in broiler chickens. This is the first time that CpG-ODN((2007)) has been demonstrated to have an immunoprotective effect against an extracellular bacterial infection in any food animal species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540567      PMCID: PMC145352          DOI: 10.1128/IAI.71.2.857-863.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  CpG DNA as a Th1 trigger.

Authors:  K Heeg; S Zimmermann
Journal:  Int Arch Allergy Immunol       Date:  2000-02       Impact factor: 2.749

Review 2.  Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.

Authors:  A M Krieg
Journal:  Biochim Biophys Acta       Date:  1999-12-10

3.  The role of CpG motifs in innate immunity.

Authors:  A M Krieg
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

4.  CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.

Authors:  F G Zhu; J S Marshall
Journal:  J Leukoc Biol       Date:  2001-02       Impact factor: 4.962

5.  Comparative pathologic findings of Escherichia coli infection in birds.

Authors:  N F Cheville; L H Arp
Journal:  J Am Vet Med Assoc       Date:  1978-09-01       Impact factor: 1.936

6.  Swollen-head syndrome in broiler chickens.

Authors:  A J Morley; D K Thomson
Journal:  Avian Dis       Date:  1984 Jan-Mar       Impact factor: 1.577

7.  CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

Authors:  G Hartmann; G J Weiner; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  The effects of DNA containing CpG motif on dendritic cells.

Authors:  S Behboudi; D Chao; P Klenerman; J Austyn
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

9.  CpG DNA induces stronger immune responses with less toxicity than other adjuvants.

Authors:  R D Weeratna; M J McCluskie; Y Xu; H L Davis
Journal:  Vaccine       Date:  2000-03-06       Impact factor: 3.641

10.  CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans.

Authors:  H L Davis; I I Suparto; R R Weeratna; D D Iskandriati; S S Chamzah; A A Ma'ruf; C C Nente; D D Pawitri; A M Krieg; W Smits; D D Sajuthi
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

View more
  18 in total

1.  The use of CpG as an adjuvant to Toxoplasma gondii vaccination.

Authors:  Jennifer A Spencer; Bruce F Smith; Anthony J Guarino; Byron L Blagburn; Henry J Baker
Journal:  Parasitol Res       Date:  2004-01-15       Impact factor: 2.289

Review 2.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

3.  Expression analysis of turkey (Meleagris gallopavo) toll-like receptors and molecular characterization of avian specific TLR15.

Authors:  Kannaki T Ramasamy; Maddula R Reddy; Prem C Verma; Shanmugam Murugesan
Journal:  Mol Biol Rep       Date:  2012-06-15       Impact factor: 2.316

4.  Characterization of Dosage Levels for In Ovo Administration of Innate Immune Stimulants for Prevention of Yolk Sac Infection in Chicks.

Authors:  Mishal Sarfraz; Thuy Thi Thu Nguyen; Colette Wheler; Wolfgang Köster; Volker Gerdts; Arshud Dar
Journal:  Vet Sci       Date:  2022-04-22

Review 5.  Antiinfective applications of toll-like receptor 9 agonists.

Authors:  Arthur M Krieg
Journal:  Proc Am Thorac Soc       Date:  2007-07

6.  CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin.

Authors:  Tao Wang; Zhi-qin Wang; Lv Wang; Li Yan; Jian Wan; Sheng Zhang; Hong-quan Jiang; Wen-fang Li; Zhao-fen Lin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

7.  Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys.

Authors:  Jean-Rémy Sadeyen; Zhiguang Wu; Holly Davies; Pauline M van Diemen; Anita Milicic; Roberto M La Ragione; Pete Kaiser; Mark P Stevens; Francis Dziva
Journal:  Vet Res       Date:  2015-01-23       Impact factor: 3.683

8.  In ovo delivery of CpG DNA reduces avian infectious laryngotracheitis virus induced mortality and morbidity.

Authors:  Simrika Thapa; Mohamed Sarjoon Abdul Cader; Kalamathy Murugananthan; Eva Nagy; Shayan Sharif; Markus Czub; Mohamed Faizal Abdul-Careem
Journal:  Viruses       Date:  2015-04-08       Impact factor: 5.048

Review 9.  Applications of In Ovo Technique for the Optimal Development of the Gastrointestinal Tract and the Potential Influence on the Establishment of Its Microbiome in Poultry.

Authors:  Stephanie M Roto; Young Min Kwon; Steven C Ricke
Journal:  Front Vet Sci       Date:  2016-08-17

10.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.